×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| ASTRAZENECA PHARMA INDIA LTD. | 5375.5 | 558.3 | 5263.1 | 22.33 | 22,500 | 106.0 |
| POLY MEDICURE LTD. | 4251.42 | 879.29 | 3840.47 | 8.67 | 20458 | 57.2 |
| ALEMBIC PHARMACEUTICALS LTD. | 15019.6 | 1035.2 | 14941.7 | 5.27 | 18620 | 31.4 |
AstraZeneca Pharma India Ltd., with Security Code 506820, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 284.7 | 295.5 | 311.1 | 305.8 | 383.2 | 387.5 | 408.0 | 440.3 | 480.5 | 526.3 |
| Expenses | 224.9 | 228.2 | 258.3 | 290.7 | 333.7 | 349.4 | 355.5 | 363.3 | 394.0 | 445.2 |
| Operating Profit | 59.8 | 67.2 | 52.8 | 15.1 | 49.5 | 38.1 | 52.5 | 77.0 | 86.5 | 81.1 |
| OPM % | 21.02% | 22.76% | 16.96% | 4.92% | 12.92% | 9.83% | 12.88% | 17.49% | 17.99% | 15.41% |
| Other Income | -32.2 | 8.1 | 24.8 | 9.7 | 8.7 | -49.2 | 8.2 | -25.6 | 10.5 | 10.9 |
| Interest | 0.1 | 0.2 | 0.5 | 0.6 | 0.1 | 0.1 | 0.3 | 0.3 | 0.7 | 0.7 |
| Depreciation | 4.2 | 3.8 | 3.7 | 3.7 | 3.8 | 3.9 | 9.3 | 9.1 | 17.7 | 16.6 |
| Profit before tax | 63.5 | 71.4 | 57.0 | 20.4 | 54.4 | 42.4 | 51.0 | 75.6 | 84.2 | 75.1 |
| Tax % | -25.8% | -24.6% | -28.6% | -22.5% | -27.4% | 22.2% | 24.7% | 26.6% | -25.7% | 25.3% |
| Net Profit | 17.3 | 53.9 | 52.4 | 15.8 | 39.5 | -11.8 | 38.4 | 30.9 | 58.3 | 55.8 |
| EPS in Rs | 6.91 | 21.54 | 20.95 | 6.32 | 15.79 | -4.72 | 15.37 | 12.34 | 0 | 22.33 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 12% |
| 3 Years: | 17% |
| TTM: | 35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 22% |
| 3 Years: | 18% |
| TTM: | 5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 21% |
| 3 Years: | 46% |
| 1 Year: | 41% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|